Home › Avant Licenses Genetic Health Solutions Patient-Delivery Platform

Avant Licenses Genetic Health Solutions Patient-Delivery Platform

Jul 13, 2017

NEW YORK (360Dx) – Avant Diagnostics on Wednesday said it has acquired an exclusive option to license Genetic Health Solution's patient-delivery technology platform.

Avant said it plans to use the platform to develop a personalized cancer patient management program that will combine blood biomarker monitoring and drug side effect profiles to help reduce negative drug side effects in cancer patients.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Nov
05
Featured Webinar

Overcoming Challenges in Solid Tumor Testing with Advanced AI

Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.

What's Popular?

In Cancer

  1. Liquid Biopsy IDs More NSCLC Mutations, Yields Patient Therapy Response in Study of Guardant Test

  2. AmoyDx Lung Cancer CDx Approved in South Korea

  3. NCCN Update on Breast Cancer Genetic Testing Guidelines Marks Oncotype DX as 'Preferred' Test

  4. Digital Pathology Startup Deep Lens Emerges From Stealth Mode

  5. Bio-Techne Inks Deal With Chinese Microfluidic Developer Micropoint Bio

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.